New hope for controlling rare liver disease in japanese patients
NCT ID NCT06730061
Summary
This study is testing whether a daily pill called elafibranor can help control primary biliary cholangitis (PBC), a rare liver disease that damages bile ducts. It will involve about 18 Japanese adults whose current treatment isn't working well enough. Researchers will check if the drug lowers key liver markers and improves symptoms like itching and fatigue over several years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chugoku Rosai Hospital
Hiroshima, Japan
-
Fukushima Medical University Hospital
Fukushima, Japan
-
Hamamatsu University Hospital
Shizuoka, Japan
-
Juntendo University Hospital
Tokyo, Japan
-
Kagawa University Hospital
Kagawa, Japan
-
Kagoshima University Hospital
Kagoshima, Japan
-
Nagaoka Red Cross Hospital
Niigata, Japan
-
Nara Medical University Hospital
Nara, Japan
-
National Hospital Organization Nagasaki Medical Center
Nagasaki, Japan
-
National Hospital Organization Osaka National Hospital
Osaka, Japan
-
Niigata University Medical & Dental Hospital
Niigata, Japan
-
Nippon Medical School - Chiba Hokusoh Hospital
Chiba, Japan
-
Shinshu University Hospital
Nagano, Japan
-
Teikyo University Hospital
Tokyo, Japan
-
Teine Keijinkai Hospital
Hokkaido, Japan
-
Tokyo Metropolitan Komagome Hospital
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.